Published on: January 2024
Indian Journal of Pharmacy Practice, 2024; 17(1):17-20
Opinion | doi:10.5530/ijopp.17.1.3
Authors:
Blessy Fernandes
Department of Pharmacy Practice, Srinivas College of Pharmacy, Mangalore, Karnataka, INDIA.
Abstract:
Ovarian cancer is a serious and complex disease that primarily affects the ovaries. Detecting it in its early stages is important for successful treatment and improved outcomes. While common symptoms such as abdominal pain, bloating, and changes in bowel or urinary habits may raise suspicion, they are often nonspecific, making early diagnosis challenging. Age, family history, and gene mutations are some common risk factors. Emerging biomarkers for early detection of ovarian cancer are CA-125, HE4, osteopontin and genetic testing. Medical professionals usually perform a combination of imaging tests and biopsy to confirm the presence of ovarian cancer. Surgery, chemotherapy, and targeted therapy are some of the possible treatments that can be chosen depending on the stage and type of cancer. Early detection and efficient treatment depend on regular checkups and awareness of possible signs.
Key words: Biomarkers, Detection, Ovarian cancer, risk factors